Board of Directors
We are united by our commitment to improving mental health.
George Goldsmith
Chairman and Co-founder
Entrepreneur dedicated to bringing about positive change in society with particular focus on health and wellbeing.
Kabir Nath
Chief Executive Officer
Experienced leader in health care industry, committed to revolutionising mental health care
Ekaterina Malievskaia MD
Co‑founder
Focuses on evidence-based and effective mental health care
David Norton
Lead Independent Director
Senior biopharma executive, and former Company Group Chairman of Global Pharmaceuticals at Johnson & Johnson
Annalisa Jenkins MBBS
Independent Director
Senior biotech executive, former Head of R&D at Merck Serono, and former Head of Global Medical Affairs at Bristol-Myers Squibb
Daphne Karydas MBA
Independent Director
President and Chief Financial Officer at Flare Therapeutics Inc., a privately held biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
Linda McGoldrick
Independent Director
Founder, Chairman and CEO of Financial Health Associates International, a strategic consulting company specialising in healthcare and life sciences
Robert McQuade PhD
Independent Director
EVP and Chief Strategic Officer at Otsuka Pharmaceutical Development & Commercialization, Inc and President of the McQuade Center for Strategic Research and Development LLC (MSRD)
Thomas Lönngren
Independent Director
Senior regulatory executive, and former Executive Director of the European Medicines Agency (EMA)
Wayne J Riley MD MPH MBA
Independent Director
President of the State University of New York (SUNY) Downstate Health Sciences University